Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure
Completed · Phase 3
Conditions studied: Respiratory Distress Syndrome, Cronic Lung Disease
In brief
The specific aims of this study are to evaluate the amount of high flow nasal cannula (HFNC) gas flow required to generate an equivalent positive distending pressure as that provided by nasal continuous positive airway pressure (NCPAP) of 6 cm H2O, assess the relationships between positive distending pressure, gas flow, oxygen requirement, and patient weight, and lastly, develop an appropriate protocol to be used in the NICU for transitioning patients from NCPAP to an equivalent amount of HFNC.
Key facts
- Study ID
- NCT00356668
- Run by
- Children's Hospitals and Clinics of Minnesota
- People needed
- 16
- Starts
- 2006-07-01
- Expected to finish
- 2007-09-01
- Last updated by the study team
- 2015-07-14
Who can join
Age: 0 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 1) receiving NCPAP ventilatory support at > 72 hrs. of age and 2) requiring FiO2 21-50% on NCPAP.
You may not qualify if…
- FiO2 >50%, presence of pneumothorax or pleural effusion, anatomical abnormalities of the airway, lungs, or esophagus, or cyanotic congenital heart defect.
Where it is running
- Children's Hospital and Clinics of Minnesota — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.